Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
US6080745A · kind A · utility
5Cited by
2References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 12, 1996 |
| Grant date | Jun 27, 2000 |
| Priority date | — |
| Expiry date | Mar 12, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A class of fused tricyclic heteroaromatic compounds of formula (I) as defined in claim 1 or a salt thereof or a prodrug thereof, containing a fused pyrazole, oxazole or pyrimidine ring are ligands for dopamine receptor subtypes within the body and are therefore of use in the treatment and/or prevention of disorders of the dopamine system, such as schizophrenia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.